XML 17 R4.htm IDEA: XBRL DOCUMENT v3.25.2
Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jul. 31, 2025
Jul. 31, 2024
Jul. 31, 2025
Jul. 31, 2024
Income Statement [Abstract]        
Net sales and revenue $ 158,563 $ 148,155 $ 316,903 $ 309,386
Cost of sales (includes $29,004 and $28,340 with related parties for the three months ended July 31, 2025 and 2024, respectively, and $53,853 and $58,987 with related parties for the six months ended July 31, 2025 and 2024, respectively.) 144,244 128,382 288,242 275,162
Gross profit 14,319 19,773 28,661 34,224
Selling, general and administrative expenses (6,201) (6,440) (12,145) (12,551)
Equity in income of unconsolidated affiliates 891 1,747 1,897 3,465
Interest and other income, net 3,088 4,416 7,310 10,321
Income before income taxes 12,097 19,496 25,723 35,459
Provision for income taxes (2,769) (4,489) (5,723) (8,179)
Net income 9,328 15,007 20,000 27,280
Net income attributable to noncontrolling interests (2,217) (2,629) (4,211) (4,711)
Net income attributable to REX common shareholders $ 7,111 $ 12,378 $ 15,789 $ 22,569
Weighted average shares outstanding – basic (in Shares) 16,505,000 17,548,000 16,694,000 17,528,000
Basic net income per share attributable to REX common shareholders (in Dollars per share) $ 0.43 $ 0.71 $ 0.95 $ 1.29
Weighted average shares outstanding – diluted (in Shares) 16,505,000 17,671,000 16,694,000 17,648,000
Diluted net income per share attributable to REX common shareholders (in Dollars per share) $ 0.43 $ 0.7 $ 0.95 $ 1.28